Treatment.com to change name to Rocket Doctor AI

Executive Summary

• Treatment.com AI Inc. is officially rebranding and reincorporating as Rocket Doctor AI Inc., aligning its corporate identity with its evolved product portfolio following the acquisition of Rocket Doctor Inc.
• The company’s common shares will begin trading on the Canadian Securities Exchange under the new ticker symbol AIDR (replacing TRUE) effective August 21, 2025.
• The rebrand unites the proprietary Global Library of Medicine (GLM) with Rocket Doctor’s digital health platform to deliver AI-enhanced clinical, diagnostic, and administrative tools, specifically targeting rural, remote, and underserved communities in North America.

Key Details

• Rebranding and Reincorporation: Treatment.com AI Inc. changes its legal name to Rocket Doctor AI Inc.
• Trading Symbol Change:
  • New Ticker: AIDR
  • Old Ticker: TRUE
  • Effective Date: August 21, 2025
  • New CUSIP: 772924106
  • New ISIN: CA7729241066
• Strategic Integration: The new entity combines Treatment.com AI’s Global Library of Medicine (GLM) with Rocket Doctor Inc.’s digital health platform and marketplace.
• Technology Focus: Leveraging large language models (LLMs), connected Bluetooth medical devices, and proprietary software to provide AI-driven administrative, diagnostic, clinical decision support, and referral solutions.
• Target Market: Focus on improving healthcare access for rural, remote, and underserved communities in Canada and the United States (including Medicaid and Medicare patients).
• Acquisition Context: This move follows the successful acquisition of Rocket Doctor Inc. in April 2025, which is described as a pivotal step toward commercialization.
• Leadership: Dr. Essam Hamza remains CEO of the rebranded entity; Dr. William Cherniak serves as CEO of Rocket Doctor Inc. within the new structure.

Notable Quotes

• Dr. Essam Hamza, CEO: "We are very excited about this next chapter for the company. This name change marks a natural step in uniting our technology and service offerings under a single, stronger identity. Following the acquisition of Rocket Doctor, we are at an important inflection point. As we move toward the next phase of commercialization and prepare for our Q2 announcement, we remain focused on delivering practical; AI driven; clinically validated; scalable solutions and keeping our shareholders informed of our progress."
• Dr. William Cherniak, CEO of Rocket Doctor Inc.: "It's been a fast-paced journey since joining the team at Treatment.com AI. We couldn't be more thrilled to take the ethos and brand brought from our work across North America to now jointly power Rocket Doctor AI. There's much more to go in our work of improving physicians' practice of medicine, while in parallel increasing access to care for patients in need; this refined name makes clear our focus on technology as a critical component to achieving these objectives. Onward and upward!"